Utilizing HALO Link and HALO AI to Enable a Large Autoimmune-Focused Research Network for Spatially Informed Disease Characterizations and Research
30 January 2025 | Learn how HALO and HALO AI are advancing the study of autoimmune diseases!
30 January 2025 | Learn how HALO and HALO AI are advancing the study of autoimmune diseases!
9 January 2025 | Join us for this 1-hour webinar for an in-depth demonstration of HALO AI’s Object Phenotyper, a cutting-edge, learn-by-example tool designed for advanced cell phenotyping.
Masterclass Webinar: Training and Deploying the HALO AI Phenotyper Read More »
An interview with Todd Camp, Applications Specialist, Clinical – Indica Labs
An interview with Todd Camp, Applications Specialist, Clinical – Indica Labs Read More »
Albuquerque, NM, October 30, 2024 – The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), among the leading institutes for clinical digital pathology and research in the European Union, has partnered with Indica Labs to implement digital primary diagnostics with integrated AI-powered image analysis.
AI is helping to advance digital pathology research by streamlining workflows, increasing reproducibility, and enabling the collection of previously intractable data.
With the HALO AP platforms and their dedicated Tumor Board functionalities, pathologists can enhance multidisciplinary communication and improve treatment planning.
10 December 2024 | Indica Labs is pleased to announce our London HALO User Group Meeting to be held in London on 10 December 2024 at Hilton London Metropole from 12:00 – 16:00.
Indica Labs’ London HALO® User Group Meeting 2024 Read More »
At Indica Labs, our HALO platforms are optimized for ease-of-use as well as powerful, accurate analysis, and include multiple features to help users get the most from their data.
Interactive Markup Images: Providing a Dynamic Look at HALO® Analysis Results Read More »